Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine in Healthy Children
NCT00133536Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2006
- Primary completion
- Apr 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of inactivated influenza a vaccine A/H5N1 in Avian Influenza (AI), sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2006; status: completed.
02
Drugs
inactivated influenza a vaccine A/H5N1
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT00133536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133536.